All Oncology Clinical Trials:
Phase 1/2 Study of Lenvatinib in Combination with Everolimus in Recurrent and Refractory Pediatric Solid Tumors, including CNS
Clinical Trial Protocol # ADVL1711 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 1 Study of ABI-009 (nab-rapamycin) in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors as a Single Agent and in Combination with Temozolomide and Irinotecan
Clinical Trial Protocol # ADVL1514 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 1/2 Study of VX15/2503 (IND# 136181) in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid Tumors
Clinical Trial Protocol # ADVL1614 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
Clinical Trial Protocol # ADVL1622 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: A Phase II Study of Dasatinib Therapy in Children and Adolescents with Newly Diagnosed Chronic Phase CML or with Ph+ Leukemias Resistant or Intolerant to Imatinib
Clinical Trial Protocol # 90325 | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer, oncology | Contact (714) 509-8646
Oncology Clinical Trials Pilot Project: Harnessing big data for new ideas in pediatric, adolescent and young adult oncology
Clinical Trial Protocol # 160778 | Adolescents and Young Adults, oncology | Contact (714) 509-8646
Oncology Clinical Trial: Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Clinical Trial Protocol # AALL05B1 | Biology/Genomics, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Study of Kidney Tumors in Younger Patients
Clinical Trial Protocol # AREN03B2 | Biology/Genomics, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Clinical Trial Protocol # AALL1131 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical Trial Protocol # AAML1031 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Clinical Trial Protocol # AALL0932 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Clinical Trial Protocol # AALL08B1 | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Clinical Trial Protocol # ACNS0831 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Study of Blood Samples From Newborns With Down Syndrome
Clinical Trial Protocol # AAML08B1 | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Clinical Trial Protocol # ALTE07C1 | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Clinical Trial Protocol # AEWS07B1 | Biology/Genomics, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Clinical Trial Protocol # AOST06B1 | Biology/Genomics, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Clinical Trial Protocol # ACNS0332 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Clinical Trial | Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Fertility Preservation in Women and Girls with Cancer
Clinical Trial | Adolescents and Young Adults, Fertility, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Clinical Trial Protocol # ACNS02B3 | Biology/Genomics, Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Clinical Trial Protocol # ACCL0933 | Leukemia/Lymphoma, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Clinical Trial Protocol # ANBL00B1 | Biology/Genomics, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Clinical Trial Protocol # ACNS0331 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Long-Term Follow-Up of Patients Who Have Participated in Children’s Oncology Group Studies
Clinical Trial Protocol # ALTE05N1 | Survivorship | Contact (714) 509-8646
